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Vaccines, Contagion, and Social Networks
Elizabeth L. Ogburn, Tyler J. VanderWeele∗
Abstract
Consider the causal effect that one individual’s treatment may have on another indi-
vidual’s outcome when the outcome is contagious, with specific application to the effect
of vaccination on an infectious disease outcome. The effect of one individual’s vaccination
on another’s outcome can be decomposed into two different causal effects, called the “in-
fectiousness” and “contagion” effects. We present identifying assumptions and estimation
or testing procedures for infectiousness and contagion effects in two different settings: (1)
using data sampled from independent groups of observations, and (2) using data collected
from a single interdependent social network. The methods that we propose for social
network data require fitting generalized linear models (GLMs). GLMs and other statisti-
cal models that require independence across subjects have been used widely to estimate
causal effects in social network data, but, because the subjects in networks are presumably
not independent, the use of such models is generally invalid, resulting in inference that is
expected to be anticonservative. We introduce a way to ensure that GLM residuals are
uncorrelated across subjects despite the fact that outcomes are non-independent. This
simultaneously demonstrates the possibility of using GLMs and related statistical models
for network data and highlights their limitations.
1 Introduction
We are concerned here with the effect that one individual’s treatment may have on another
individual’s outcome, when the outcome is contagious. In the infectious disease literature, this
is often called an indirect effect of treatment (Halloran and Struchiner, 1991), while the effect
of an individual’s treatment on his own outcome is a direct effect. Indirect effects of infectious
disease interventions are of significant importance for understanding infectious disease dynam-
ics and for designing public health interventions. For example, the goal of many vaccination
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programs is to achieve herd immunity, whereby a large enough subset of a population is vac-
cinated that even those individuals who remain unvaccinated are protected against infection.
This is one type of indirect effect of a vaccination program; it has been extensively stud-
ied in the infectious disease literature (Anderson et al., 1985; Fine, 1993; John and Samuel,
2000; O’Brien and Dagan, 2003). Recently, interest has turned towards the identification and
estimation of average individual-level indirect effects (Halloran and Struchiner, 1991, 1995;
Halloran and Hudgens, 2012; VanderWeele and Tchetgen Tchetgen, 2011a; VanderWeele et al.,
2012b; VanderWeele and Tchetgen Tchetgen, 2011b), such as the effect on a single member of
a community of two different vaccination programs implemented on the rest of the community
(Halloran and Struchiner, 1995).
VanderWeele et al. (2012b) demonstrated that the individual-level indirect effect of vacci-
nation in communities of size two can be decomposed into to two different effects, called the
“infectiousness” and “contagion” effects. These two effects represent distinct causal pathways
by which one person’s vaccination may affect another’s disease status. The contagion effect is
the indirect effect that vaccinating one individual may have on another by preventing the vac-
cinated individual from getting the disease and thereby from passing it on. The infectiousness
effect is the indirect effect that vaccination might have if, instead of preventing the vaccinated
individual from getting the disease, it renders the disease less infectious, thereby reducing the
probability that the vaccinated infected individual transmits the disease, even if infected.
VanderWeele et al. (2012b) only considered estimation of the infectiousness and conta-
gion effects in a sample comprised of independent households of size two with one member
of each household assumed to be homebound. The assumption that one individual is home-
bound and the assumption of independent households are restrictive, the latter because it
requires that the households be sampled from distinct communities and geographic areas.
Ogburn and VanderWeele (2013) considered the setting in which households are independent
but both individuals may be exposed outside the household. Here, we relax the requirement of
independent households of size two and provide extensions to independent groups of arbitrary
size and to social networks.
Increasingly, data are available on the spread of contagious outcomes through social net-
works. This setting is considerably more complex than that considered in VanderWeele et al.
(2012b), because the observed outcomes (e.g. disease status) are not independent of one an-
other. There is a growing literature on the possibility of testing for the presence of different
causal mechanisms using observational data from social networks and a consensus that more
rigorous methods are needed.
An emerging body of work reports results from generalized linear models (GLMs) and,
for longitudinal data, generalized estimating equations (GEEs) as estimates of peer effects, or
the causal effect that one individual’s outcome may have on his or her social contacts’ out-
comes (Ali and Dwyer, 2009; Cacioppo et al., 2009; Christakis and Fowler, 2007, 2008, 2013;
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Fowler and Christakis, 2008; Lazer et al., 2010; Rosenquist et al., 2010). This work has come
under criticism that can largely be summarized into two overarching themes. First, much of
the criticism focuses on the ability to control for confounding when estimating peer effects,
and specifically on the identifying assumptions that are required in order to tell the differ-
ence between the well known problem of homophily (the phenomenon by which individuals
with similar traits are more likely to form social ties with one another) and peer influence
(Cohen-Cole and Fletcher, 2008; Lyons, 2011; Noel and Nyhan, 2011; Shalizi and Thomas,
2011; VanderWeele, 2011). Homophily will not be an issue in many infectious disease set-
tings, as many such illnesses, for example the seasonal flu, are unlikely to change the nature
of social ties. Adequate control for confounding is still crucial, but we assume throughout
that all potential confounders of the causal effects of interest are observed. This assumption
should be assessed in any application of these methods and it may not hold in many real data
settings; however, we do not focus on this assumption in the remainder of this paper.
The second class of criticisms addresses the use of statistical models for independent obser-
vations in this dependent data setting. Lyons (2011) and VanderWeele et al. (2012a) demon-
strated the importance of ensuring that models are coherent when an observation can be both
an outcome and a predictor (of social contacts’ outcomes); this is easily accomplished by using
the observations at one time point as predictors and the observations at a subsequent time
point as outcomes, a solution that was implemented in many of applications of GLMs and
GEEs to social network data referenced above. More challenging is the fact that, when an
analysis assumes independence but observations are in fact positively correlated, as we would
expect them to be for contagious outcomes in a social network, the resulting standard errors
and statistical inference will generally be anticonservative. In some cases, the assumption of
independent outcomes may hold under the null hypothesis (VanderWeele et al., 2012a), but it
is unknown whether tests that rely on this fact have any power to detect the presence of the
causal effects of interest (Shalizi, 2012).
Our contribution to methodology for social network analysis is to adapt GLMs to ensure
that the models can be correctly specified, with uncorrelated residuals, even when the out-
come is contagious. We demonstrate the possibility of testing for the presence of contagion
and infectiousness effects using social network data and generalized linear models (GLMs).
We discuss the paradigmatic example of the effect of a vaccination on an infectious disease
outcome, but effects like contagion and infectiousness are of interest in other settings as well.
Our general approach to correctly specifying GLMs for a contagious outcome using network
data could potentially be applied to any estimand for which GLMs are appropriate under
independence. The tests that we propose have important limitations, most notably low power
to detect effects unless networks are large and/or sparse. However, this work represents an
important proof of concept in the ongoing endeavor to develop methods for valid inference
using data collected from a single network. Furthermore, it clarifies the issues of model mis-
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specification and invalid standard errors raised by previous proposals for using GMLs to assess
peer effects using network data.
2 Social networks and contagion
Formally, a social network is a collection of individuals and the ties between them. The
presence of a tie between two individuals indicates that the individuals share some kind of a
relationship; what types of relationships are encoded by network ties depends on the context.
For example, we might define a network tie to include familial relatedness, friendship, and
shared place of work. Some types of relationships are mutual, for example familial relatedness
and shared place of work. Others, like friendship, may go in only one direction: Tom may
consider Sue to be his friend, while Sue does not consider Tom to be her friend. We will assume
that all ties in our network are mutual or undirected, but the principles of our method extend
to directed ties. A node whose characteristics we wish to explain is called an ego; nodes that
share ties with the ego are its alters or contacts. If an ego’s outcome may be affected by his
contacts’ outcomes, then we say that the outcome exhibits induction or contagion.
Social networks are crucial to understanding many features of infectious disease dynamics,
and, increasingly, infectious disease researchers draw on social network data to refine their
understanding of transmission patterns and treatment effects. For example, many mathe-
matical models of infectious disease now incorporate social network structure, whereas they
previously generally assumed uniform mixing among members of a community (Eubank et al.,
2004; Klovdahl, 1985; Klovdahl et al., 1994; Keeling and Eames, 2005), and researchers collect
data on sexual contact networks, since properties of these networks can inform strategies for
controlling sexually transmitted diseases (Latora et al., 2006; Eames and Keeling, 2002, 2004).
It is desirable for a number of reasons to study infectiousness and contagion in the context
of social networks rather than in independent communities. First, social network data may
be easier to collect or to access than data on independent communities, as the latter setting
requires sampling from a large number of different locations or contexts that are separated
by time or space. Second, assessing whether traits can be transmitted from one individual to
another through network ties is one of the central questions in the study of social networks;
assessing infectiousness and contagion contributes further insight into this problem. Finally,
social network data more realistically capture the true interdependencies of the individuals
whom we can hope to treat with any public health intervention. Vaccine programs do not
in general target distant, independent pairs of individuals; they target villages, cities, or
communities in which individuals are interconnected and their outcomes correlated. Therefore,
assessing the presence of vaccine effects in social network data may be more informative for
real-world applications. The methods we present here represent a first step towards being able
to estimate and perform inference about such effects using social network data.
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Interventions to prevent infectious diseases generally operate in two ways. Some reduce the
susceptibility of treated individuals to the disease, thereby preventing them from becoming
infected. Examples of such interventions are vaccines for tetanus, hepatitis A and B, rabies,
and measles (Keller and Stiehm, 2000). These vaccines have indirect effects that operate via
contagion effects. Other interventions may reduce the likelihood that an infected individual
passes on his infection to others. The malaria transmission-blocking vaccine is designed to
prevent mosquitos from acquiring, and thereby from transmitting, malaria parasites upon
biting infected individuals (Halloran and Struchiner, 1992). This vaccine has no protective
effect for the vaccinated individual, but it renders vaccinated individuals less likely to transmit
the disease. Therefore any indirect effect of the malaria transmission-blocking vaccine is due
entirely to an infectiousness effect. Many interventions have indirect effects that operate via
both contagion and infectiousness effects.
Existing methods for assessing causal effects using network data are limited. Some re-
cent proposals give methods for assessing indirect effects when treatment can be randomized
(Airoldi et al., 2013; Aronow and Samii, 2012; Bowers et al., 2013; Rosenbaum, 2007), but
these methods are of limited use in observational settings or for teasing apart specific types
of indirect effects like the infectiousness and contagion effects. Much of the extant literature
relies on GLMs and GEEs, despite the fact that the key assumption of independent outcomes
across subjects is unlikely to hold in social network settings (Lyons, 2011). In this paper, we
introduce a way to ensure that GLM residuals are uncorrelated across subjects despite the fact
that outcomes are non-independent; this facilitates the use of GLMs to assess infectiousness
and contagion effects in social network contexts. We demonstrate through simulations that
our methods do have some power to detect the presence of contagion and infectiousness effects;
however, in order to ensure that residuals are uncorrelated, we make several adaptations to
naive GLMs; unfortunately these can result in low power. The applications that we discuss
in this paper do not require the use of GEEs to account for within-subject dependence over
time, but the general principles that we use to adapt GLMs to the network setting apply to
GEEs as well.
3 Infectiousness and contagion in independent groups of size 2
3.1 Notation and assumptions
Consider K households comprised of two individuals each and separated by space or time such
that an infectious disease cannot be transmitted between individuals in different households.
Borrowing terminology from the social network literature, we will refer to one individual as
the alter, denoted a, and the other as the ego, denoted e. For now we assume that in each
household the ego is unvaccinated, and that all vaccination occurs before the start of follow-up.
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Contagion and infectiousness effects are analogous to causal mediation effects of the alter’s
vaccination on the ego’s outcome, mediated by the alter’s disease status (VanderWeele et al.,
2012b). We formally define these effects in the next section after first introducing key notation
and identifying assumptions.
For individual i in household k, i = a, e, let Y tik be the outcome at time t and Cik be a
vector of covariates. Let Vak be an indicator of vaccination for the alter in household k. Below
we omit the subscript k when context allows. Define Y tik(v) to be the counterfactual outcome
we would have observed for individual i in household k at time t, if, possibly contrary to fact,
the alter had received treatment v. Let Mk be a variable that lies on a causal pathway from
Vak to Y
t
ek
. Let Y tek(v,m) be the counterfactual outcome for the ego at time t that we would
have observed if Vak had been set to v and Mk to m. Throughout we make the consistency
assumptions thatMk(v) = Mk when Vak = v, that Yek(v,m) = Yek when Vk = v andMk = m,
and that Yek(v,Mk(v)) = Yek(v). Let Y
t
ek
(v,Mk(v
′)) be the counterfactual disease status for
the ego in household k that we would have observed at time t if Vak had been set to v and Mk
to its counterfactual value under Vak = v
′. To ensure that this counterfactual is well-defined,
we assume that it is hypothetically possible to intervene on the mediator without intervening
on Vak . Let Ck = (Cak , Cek). In order to identify functionals of nested counterfactuals like
Y te (v,M(v
′)) we require the following four assumptions (Pearl, 2001):
Y te (v,m) ⊥ Va
∣∣∣C, (1)
Y te (v,m) ⊥M
∣∣∣Va,C, (2)
M (v) ⊥ Va|C, (3)
and
Y te (v,m) ⊥M
(
v′
)∣∣∣C (4)
where A ⊥ B | C denotes that A is independent of B conditional on C. Assumptions (1), (2),
and (3) correspond to the absence of unmeasured confounders for the effects of the exposure on
the outcome (Va on Y
t
e ), of the mediator on the outcome (M on Y
t
e ), and of the exposure on the
mediator (Va on M), respectively. Assumption (4) requires that no confounder of the effect of
M on Y te is affected by Va. Discussion of these assumptions in the context of mediation analysis
can be found in Pearl (2001). Discussion and extension of these assumptions to settings with
interference or spillover effects can be found in Ogburn and VanderWeele (2013), including
discussion of how to determine which covariates must be included in C.
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3.2 Previous methodology for decomposing the indirect effect into infec-
tiousness and contagion effects
3.2.1 Identification
VanderWeele et al. (2012b) described the decomposition of indirect effects into contagion and
infectiousness effects in communities of size two. They assumed that the outcome can only
occur once for each individual during the follow-up period. This is a reasonable assumption
for many infectious disease outcomes, for example for the common flu with a follow-up period
consisting of a single flu season. They further assumed that in each pair the ego cannot be
exposed to the disease except by the alter, as might be the case if the ego were homebound.
Let tf be the time of the end of follow-up and Y
tf
ke be an indicator of whether the ego in
household k has had the disease by the end of follow-up. VanderWeele et al. (2012b) defined
the population average indirect effect of vaccination on the ego as E
[
Y
tf
e (1)
]
− E
[
Y
tf
e (0)
]
,
or the expected difference in the counterfactual disease status of the ego at end of follow-up
when the alter is vaccinated compared to when the alter is not vaccinated. When the ego
is homebound, the indicator Y
tf
ke of whether the ego in household k has had the disease by
the end of follow-up is, equivalently, an indicator of whether the ego was infected by the
alter in household k. In order to generalize the discussion of vaccine effects to settings in
which the ego can be infected from outside the home, the outcome Y
tf
ke should be defined
more precisely as the indicator of whether the ego was sick after the alter. Specifically, let
Y
tf
ke = I(alter was sick at time T < tf and ego was sick at time S, T < S ≤ tf ).
The contagion effect is the protective effect that treating one individual has on another’s
disease status by preventing the treated individual from getting the disease and thereby from
transmitting it. Let Tk be the time of the first case of the disease in household k. This is
akin to the effect of one individual’s treatment on another’s disease status as mediated by the
first individual’s disease status. For the purposes of the analysis below, we define a disease
case to begin when an individual becomes infectious. If infectiousness does not coincide with
the appearance of disease symptoms then we may not observe the timing of disease cases
directly, but we could infer the time based on when symptoms appear and on known disease
dynamics. For example, an individual with the flu will generally be infectious one day before
he is symptomatic (Earn et al., 2002). Therefore, if flu is the disease under study we would
classify an individual as having the disease beginning one day before he reported having flu
symptoms. We assume throughout that there are no asymptomatic carriers of the disease.
If neither individual in household k is ever sick then we define Tk to be the end of follow-
up. Now Y Tkak is an indicator of whether the alter is sick at time Tk, i.e. an indicator of
whether the alter is the first individual in the group to get sick; if neither individual gets sick
then it will be 0. Let Tk(v) be the time at which the first infection in household k would
have occurred if the alter had, possibly contrary to fact, had vaccine status v. Let Y
Tk(v)
ak (v)
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be the counterfactual disease status of the alter at time Tk(v) had he had vaccine status v.
Let Y
tf
ek = I(individual ekbecame infectious after time Tkand on or before time tf ). The con-
tagion effect is given by a contrast in counterfactuals of the form Y
tf
e
(
v, Y
T (v′)
a (v′)
)
where,
unlike in the mediation framework we described in Section 3.1, the variable Y
T (v′)
a that plays
the role of mediator may be a different random variable in the two terms in the contrast. Specif-
ically, the population average contagion effect is E
[
Y
tf
e
(
0, Y
T (1)
a (1)
)]
−E
[
Y
tf
e (0, Y
T (0)
a (0))
]
,
and Y
T (0)
a and Y
T (1)
a will be different random variables whenever T (0) 6= T (1). This contrast
is the difference in expected counterfactual outcomes for the ego when the vaccine status of
the alter is held constant at 0 but his infection status is set to that under vaccination in the
first term and to that under no vaccination in the second term of the contrast. It captures
the effect that vaccination might have had on the disease status of the ego by preventing the
alter from contracting the disease. The nested counterfactuals are well-defined because we can
imagine intervening on Y Tkka without intervening on Vka, for example by administering immune
boosters to prevent the alter from being infected or by exposing the alter to a high dose of flu
virus in a laboratory setting to cause infection.
The population average infectiousness effect is E
[
Y
tf
e
(
1, Y
T (1)
a (1)
)]
−E
[
Y
tf
e (0, Y
T (1)
a (1))
]
.
This is akin to the effect of one individual’s treatment on another’s disease status, not mediated
through the first individual’s disease status. This effect operates if treatment renders cases
of disease among treated individuals less likely to be transmitted. Suppose that the alter in
group k would get the flu first if vaccinated. That is, Y
Tk(1)
ak (1) = 1. Then the infectiousness
effect is the difference in counterfactual outcomes for the ego comparing the scenario in which
the alter is vaccinated and infected first with the scenario in which to the alter is unvaccinated
and infected first. If the alter in group k would not get the flu first under vaccination, then
the infectiousness effect for group k is null.
By the consistency assumption we made in Section 3.1 above, E
[
Y
tf
e
(
1, Y
T (1)
a (1)
)]
=
E
[
Y
tf
e (1)
]
and E
[
Y
tf
e
(
0, Y
T (0)
a (0)
)]
= E
[
Y
tf
e (0)
]
. The indirect effect of the vaccination of
the alter on the ego decomposes into the sum of the contagion and infectiousness effects as
follows:
E
[
Y
tf
e (1)
]
− E
[
Y
tf
e (0)
]
= E
[
Y
tf
e
(
1, Y T (1)a (1)
)]
− E
[
Y
tf
e
(
0, Y T (0)a (0)
)]
= E
[
Y
tf
e
(
1, Y T (1)a (1)
)]
− E
[
Y
tf
e (0, Y
T (1)
a (1))
]
+ E
[
Y
tf
e
(
0, Y T (1)a (1)
)]
− E
[
Y
tf
e (0, Y
T (0)
a (0))
]
The assumptions made by VanderWeele et al. (2012b) allow for the identification of the
infectiousness and contagion effects even if disease status is only observed at the end of follow-
up. Because the ego cannot be infected except by the alter, Y Tkak = 0 if and only if neither
individual is observed to get sick and Y Tkak = 1 if and only if Y
tf
ak = 1. Therefore Y
tf
ak can be
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substituted for Y Tkak in the expressions above.
Ogburn and VanderWeele (2013) gave identifying assumptions for the infectiousness and
contagion effects in groups of size two when the time of infections is observed. They did
not assume that only one member of each pair is exposed from outside of the group; instead
they assumed that the probability of the ego contracting the disease within a fixed follow-up
interval if exposed at time t is constant in t. This ensures that the time of the first infection T
is not a confounder of the mediator-outcome relationship, which would constitute a violation
of assumption (4) because T is affected by Va. Suppose that the two members of each pair
are distinguishable from one another, for example parent-child pairs. We select one of the
two to be the alter (e.g the parent) and the other is the ego (the child). Alternatively, if the
individuals are exchangeable, that is, if we have no reason to think that the indirect effect
and its components will be different for one than for the other, then we can randomly choose
which subject is the alter and which is the ego. Ogburn and VanderWeele (2013) defined the
indicator Y T+se of whether the ego is sick after time T and by time T + s to be the outcome,
where s is a constant that allows T to determine a new end of follow-up. This ensures that T
does not confound the mediator-outcome relationship. The constant s should be chosen to be
the sum of the infectious period (f) and the incubation period (b) of the disease under study.
The infectious period is the length of time during which an infected individual is infectious, and
the incubation period is the length of time between being infected and becoming infectious. If
the alter becomes infectious at time T , then he can infect the ego until time T + f . If infected
at time T + f , the ego will become infectious at time Tk + f + b = Tk + s. Therefore if the
alter infects the ego, the ego must be infectious by time Tk + s. We assume throughout that
the time to efficacy of vaccine is immediate and that the infectious and incubation periods are
constant across individuals.
Let Y
Tk(v
′)+s
ek
(
v, Y
Tk(v
′)
ak (v
′)
)
be the counterfactual outcome we would have observed for the
ego in group k at time Tk(v
′)+s if the alter’s vaccine status were set to v and the alter’s disease
status at time Tk(v
′) were set to its counterfactual under vaccine status v′. The average con-
tagion effect in this setting is given by E
[
Y
T (1)+s
e
(
0, Y
T (1)
a (1)
)]
− E
[
Y
T (0)+s
e
(
0, Y
T (0)
a (0)
)]
and the average infectiousness effect by E
[
Y
T (1)+s
e
(
1, Y
T (1)
a (1)
)]
− E
[
Y
T (1)+s
e
(
0, Y
T (1)
a (1)
)]
.
The sum of these two effects is the average indirect effect E
[
Y
T (1)+s
e (1)
]
− E
[
Y
T (0)+s
e (0)
]
.
Although the disease status of the ego is measured s days after the first infection instead of
at the end of follow-up, this indirect effect still captures any effect that the alter’s vaccination
status can have on the ego’s disease status, because after time T + s any change in the disease
status of the ego cannot be caused by Va.
So far we have described all effects on the difference scale, but everything we have written
applies equally to effects on the ratio and odds ratio scales. On the ratio and odds ratio
scales the indirect effect of vaccination decomposes into a product of the contagion and in-
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fectiousness effects. On the ratio scale, the average indirect effect of Va on the disease status
of the ego is E
[
Y
T (1)+s
e (1)
]
/E
[
Y
T (0)+s
e (0)
]
, which is a product of the average infectiousness
effect, E
[
Y
T (1)+s
e
(
1, Y
T (1)
a (1)
)]
/E
[
Y
T (1)+s
e (0, Y
T (1)
a (1))
]
, and the average contagion effect,
E
[
Y
T (1)+s
e
(
0, Y
T (1)
a (1)
)]
/E
[
Y
T (0)+s
e (0, Y
T (0)
a (0))
]
. On the odds ratio scale for a binary out-
come the decomposition is
E
[
Y
T (1)+s
e (1)
] (
1− E
[
Y
T (0)+s
e (0)
])
E
[
Y
T (0)+s
e (0)
] (
1− E
[
Y
T (1)+s
e (1)
])
=
E
[
Y
T (1)+s
e
(
1, Y
T (1)
a (1)
)] (
1− E
[
Y
T (1)+s
e (0, Y
T (1)
a (1))
])
E
[
Y
T (1)+s
e (0, Y
T (1)
a (1))
] (
1− E
[
Y
T (1)+s
e
(
1, Y
T (1)
a (1)
)])
×
E
[
Y
T (1)+s
e
(
0, Y
T (1)
a (1)
)] (
1− E
[
Y
T (0)+s
e (0, Y
T (0)
a (0))
])
E
[
Y
T (0)+s
e (0, Y
T (0)
a (0))
] (
1− E
[
Y
T (1)+s
e
(
0, Y
T (1)
a (1)
)])
where the first line is the indirect effect, the second line is the infectiousness effect, and the
third line is the contagion effect.
3.2.2 Estimation
The contagion and infectiousness effects are analogous to the natural indirect and direct ef-
fects, respectively, of the effect of Va on Y
T+s
e with Y
T
a as the mediator. Natural indirect
and direct effects have been written about extensively in the causal inference and media-
tion literature (see e.g. Pearl, 2001; Robins and Greenland, 1992; Robins and Richardson,
2010) and it is well-known how to estimate them in a variety of settings (Imai et al., 2010;
Valeri and VanderWeele, 2013). This setting differs from those considered by other authors
because the outcome Y T+se is, by definition, equal to 0 whenever Y
T
a is equal to 0; therefore
one must be careful to ensure that any model specified for for E
[
Y T+se | Va, Y
T
a ,C
]
is consis-
tent with this restriction. VanderWeele et al. (2012b) describe how to estimate the contagion
and infectiousness effects on the ratio scale in households of size two when one individual is
homebound, but the procedure they present overlooks this restriction and therefore the models
they suggest may fail to converge.
We describe a procedure for estimating the contagion and infectiousness effects that is
appropriate for the setting considered in VanderWeele et al. (2012b) and for the setting in
which neither individual is assumed to be homebound. We describe estimation of the effects
on the difference and ratio scales. Estimation of effects on the odds ratio scale is also possible.
Suppose that assumptions (1) through (4) hold for the effect of Va on Y
T+s
e with Y
T
a as the
10
mediator and covariates C, and that the following two models are correctly specified:
log
{
E
[
Y T+se | Va, Y
T
a = 1,C
]}
= γ0 + γ1Va + γ
′
2C (5)
logit
{
E
[
Y Ta | Va,C
]}
= η0 + η1Va + η
′
2C. (6)
If the outcome is rare then (5) can be replaced with a logistic model. The contagion effect
conditional on covariates C = c on the difference scale is given by
E
[
Y T (1)+se (0, Y
T (1)
a (1)) | c
]
− E
[
Y T (0)+se (0, Y
T (0)
a (0)) | c
]
= 0 + E
[
Y T+se | Va = 0, Y
T
a = 1, c
] {
E
[
Y Ta | Va = 1, c
]
− E
[
Y Ta | Va = 0, c
]}
= eγ0+γ
′
2
c
{
eη0+η1Va+η
′
2
c
1 + eη0+η1Va+η
′
2
c
−
eη0+η
′
2
c
1 + eη0+η
′
2
c
}
.
and the infectiousness effect conditional on covariates C = c is given by
E
[
Y T (1)+se (1, Y
T (1)
a (1)) | c
]
− E
[
Y T (1)+se (0, Y
T (1)
a (1)) | c
]
= 0 +E
[
Y Ta | Va = 1, c
] {
E
[
Y T+se | Va = 1, Y
T
a = 1, c
]
− E
[
Y T+se | Va = 0, Y
T
a = 1, c
]}
=
eη0+η1Va+η
′
2
c
1 + eη0+η1Va+η
′
2
c
{
eγ0+γ1Va+γ
′
2
c − eγ0+γ
′
2
c
}
.
The contagion and infectiousness effects can be estimated by fitting models (5) and (6) and
plugging the parameter estimates into the expressions above. The standard errors for these
estimates can be bootstrapped or derived using the delta method (similar to those derived
in Valeri and VanderWeele, 2013 for the natural direct and indirect effects). Alternatively,
a Monte Carlo based approach similar to Imai et al. (2010) can be used for estimation of
the effects and their standard errors. Software packages like SAS and SPSS mediation macros
(Valeri and VanderWeele, 2013) or the R mediation package (Imai et al., 2010) cannot be used
in this setting because instead of (5), which models the conditional expectation of the Y T+se
only in the Y Ta = 1 stratum, these packages require fitting a model for E
[
Y T+se | Va, Y
T
a ,C
]
.
If the ego can also be vaccinated then Ve must be included in C. If Va interacts with Ve
or with any other covariates, these interactions can be incorporated into the models and pose
no difficulty for estimation. To test whether there is a contagion effect, we can simply test
whether η1 = 0. To test whether there is an infectiousness effect we can simply test whether
γ1 = 0.
Using the parameters of models (5) and (6) we can also estimate the contagion and in-
fectiousness effects on the ratio scale. The contagion effect conditional on C = c is given
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by
E
[
Y
T (1)+s
e (0, Y
T (1)
a (1)) | c
]
E
[
Y
T (0)+s
e (0, Y
T (0)
a (0)) | c
] = 0 + E
[
Y T+se | Va = 0, Y
T
a = 1, c
]
E
[
Y Ta | Va = 1, c
]
0 + E
[
Y T+se | Va = 0, Y Ta = 1, c
]
E [Y Ta | Va = 0, c]
=
E
[
Y Ta | Va = 1, c
]
E [Y Ta | Va = 0, c]
=
eη1 + eη0+η1+η
′
2
c
1 + eη0+η1+η
′
2
c
(7)
and the infectiousness effect is given by
E
[
Y
T (1)+s
e (1, Y
T (1)
a (1)) | c
]
E
[
Y
T (1)+s
e (0, Y
T (1)
a (1)) | c
] = 0 + E
[
Y T+se | Va = 1, Y
T
a = 1, c
]
E
[
Y Ta | Va = 1, c
]
0 + E
[
Y T+se | Va = 0, Y Ta = 1, c
]
E [Y Ta | Va = 1, c]
=
E
[
Y T+se | Va = 1, Y
T
a = 1, c
]
E
[
Y T+se | Va = 0, Y Ta = 1, c
] (8)
= eγ1 .
Under the restriction that Y T+se = 0 whenever Y
T
a = 0, the contagion effect on the ratio
scale is simply a measure of the effect of the alter’s vaccination on the alter’s outcome. It is
mathematically undefined if E
[
Y T+se | Va = 0, Y
T
a = 1, c
]
= 0, that is, if the ego’s outcome
has no effect on the alter’s outcome, but it is natural to define it to be equal to the null value
of 1 in this case. The infectiousness effect on the ratio scale is simply a measure of the effect
of the alter’s vaccination on the ego’s outcome among pairs in which the alter is sick first, that
is, in the Y Ta = 1 stratum.
4 Infectiousness and contagion in groups of more than two
Although allowing both individuals in a household to be infected from outside the household
generalizes the results of VanderWeele et al. (2012b), it still requires the strong assumption,
inherent in the identifying assumptions described in Section 3, that the alter and ego do not
share any potentially infectious contacts. If both of the individuals in a given household could
be infected from outside the household by the same mutual friend, then that friend’s disease
status would be a confounder of the mediator-outcome relationship; if unobserved, it would
constitute a violation of assumption (2). We can relax the assumption of no mutual contacts
outside of the household by collecting data on any such contacts and controlling for them as
covariates in our estimating procedure.
In this section, we consider identification and estimation of the contagion and infectiousness
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effects when independent groups of individuals are sampled. We assume that each group
includes a pair of individuals who furnish the exposure, mediator, and outcome variables,
plus all mutual and potentially infectious contacts of the pair. Several types of sampling
procedures could give rise to this data structure. For example, one possibility would be
to sample workplaces and randomly select two individuals to play the role of the alter and
ego; another would be to sample household pairs first, ascertain the identities of potential
mutual contacts outside of the home, and include all such contacts in the data collection
moving forward. The sampling procedure does not affect the identification or estimation
results described below.
Let k index the kth group, k = 1, ...,K. Let Y tik be an indicator of whether individual i
in group k has had the disease by day t. As in Section 3, we define a case of the disease to
begin when the individual becomes infectious and let s = f + b be the sum of the infectious
and incubation periods for the disease. We assume that vaccination occurs before the start
of follow-up. Given a non-rare outcome like the flu and time measured in discrete intervals
like days, it is likely that we would observe multiple individuals to get sick on the same day.
We therefore do not make the assumption, made in Section 3, that no two individuals can be
observed to get sick at the same time. For group k, let ek index the ego, whose flu status we
wish to study, and let ak index the alter, whose vaccination status may or may not have an
effect on the ego’s disease status. We index the other individuals in group k by 1, 2, ..., nk .
Let Tk be the time of the first infection in the k
th alter-ego pair. As in Section 3, the ego
furnishes the outcome, Y Tk+sek . The alter furnishes the treatment, vaccine status Vak , and the
mediator, indicator of first infection Y Tkak . When context allows, we omit the subscript k. The
definition of the mediator needs to be modified slightly to reflect the fact that the alter and
the ego could get sick at the same time: let Y Ta be an indicator of whether the alter was sick
and the ego healthy at time T . Let Y T+se be an indicator of whether the ego got sick between
time T + b, which is the first time at which the alter could have infected the ego, and time
T + s, which is the last time at which the alter could have infected the ego. This definition
preserves the interpretation of Y Ta as an indicator that the alter was sick before the ego; if the
ego and the alter simultaneously fell ill on day T then Y Ta will be 0, which is desirable because
the ego cannot have caught the disease from the alter if they both fell ill on the same day. It
also preserves the restriction, discussed in Section 3, that Y T+se is equal to 0 whenever Y
T
a is.
Y
T (v′)+s
e
(
v, Y
T (v′)
a (v′)
)
is the counterfactual flu status of the ego at time T (v′)+s had the
alter’s vaccine status been set to v and his flu status at time T (v′) set to its counterfactual
value under vaccine status v′, where T (v′) is the time at which the first infection in the alter-
ego pair would have occurred if Va had been set to v
′. The effects of interest are the average
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contagion effect
Con =
E
[
Y
T (1)+s
e
(
0, Y
T (1)
a (1)
)]
E
[
Y
T (0)+s
e
(
0, Y
T (0)
a (0)
)] (9)
and the average infectiousness effect
Inf =
E
[
Y
T (1)+s
e
(
1, Y
T (1)
a (1)
)]
E
[
Y
T (1)+s
e
(
0, Y
T (1)
a (1)
)] , (10)
where the expectations are taken over all ego-alter pairs.
In order to identify the effects defined in (9) and (10), we must measure and control for
all confounders of the relationships between Y T+se and Y
T
a , and in particular the potential
mutual infectious contacts of the alter and ego. To motivate our procedure for controlling for
these confounding contacts, consider the simple case of a group of size three, comprised of a
child (ego), a parent (alter), and a grandparent. In the event that the grandparent contracted
the flu first and transmitted it to both the child and the parent, the grandparent’s flu status
would clearly be a confounder of the mediator-outcome relationship. But the grandparent’s
entire disease trajectory is not a potential confounder; in particular anything that happens to
the grandparent after time T , that is after the first infection in the parent-child pair, occurs
after the mediator and cannot possibly confound the mediator-outcome relationship. In this
simple, three-person group, it suffices to control for an indicator of whether the grandparent
has been sick by time T − b, where T is the time of the first infection between the parent and
child, and T − b is the latest time at which the grandparent could have been the cause of an
infection at time T .
In practice, we will likely have to sample groups of size greater than three in order to
control for confounding by potential mutually infectious contacts. It is generally sufficient to
control for a summary measure of the infections occurring before T − b in each group. If each
infectious contact of an individual has an independent probability of transmitting the disease
to the individual, then the sum
∑nk
i=1 Y
T−b
ki of indicators of whether each mutual contact has
been sick by time T − b suffices to control for confounding by potential mutual infectious
contacts. Under a different transmission model, the proportion
∑nk
i=1 Y
T−b
ki /nk of contacts
who were sick by time T − b could be the operative summary measure. If some of the mutual
contacts may have been vaccinated, then separate summary measures (sum or proportion sick
by time T − b) should be included for vaccinated and for unvaccinated contacts. In what
follows we will assume that the sum is an adequate summary measure.
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4.1 Alternative sampling schemes
Alter-centric sampling can also be used to collect data on variables that suffice to identify
the contagion and infectiousness effects. Instead of sampling an alter-ego pair and all of their
mutual contacts, we can sample an individual to serve as the alter and all of his potentially
infectious contacts. The ego is randomly selected from among the alter’s contacts. Conditional
on the number of the alter’s contacts who have been infectious by day T−b, Y Ta is independent
of the number of mutual contacts who were sick by time T−b. The number of mutual contacts
is no longer a confounder of the relationship between Y Ta and Y
T+s
e and there is no need to
ascertain the identity or disease status of the mutual contacts. However, the number of
potentially infectious contacts of a single person can be vast, and it may be easier to identify
mutual contacts of a pair of individuals than all contacts of any one individual.
5 Infectiousness and contagion in social networks
So far, we have assumed that our observations, comprised of groups of individuals, were
independent of one another. This assumption will, in general, be violated when the alter-
ego pairs are sampled from a single community or social network. We introduce some new
notation for this context after briefly describing the example that will serve as the basis for
our exposition and later for our simulations and data analysis. Consider tracking the seasonal
flu in the student population of a college at which all students live in dorms on campus. Each
student is a node in the network. We define a tie to exist between two nodes if the individuals
regularly interact with one another in a way that could facilitate transmission of the flu. For
example, if two individuals are roommates, eat together in the dining hall, or are close friends,
then their nodes share a tie. We observe each individual’s flu status every day over the course
of the flu season, which lasts for 100 days.
The contagion and infectiousness effects Con and Inf , defined in Section 4, are not es-
timable from social network data using the methods that we propose below. Instead we can
define new contagion and infectiousness effects such that hypothesis tests based on the new
effects are valid and consistent tests of the hypotheses that Con and Inf are null. We give
assumptions under which the new estimands are estimable from network data using GLMs and
we demonstrate that tests of the hypotheses for the new estimands are valid and consistent
for Con and Inf .
5.1 Assumptions
Along with assumptions (1) - (4), we make several additional assumptions that facilitate
inference using social network data. Define Ai = {j : i and j share a tie} to be the collection
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of indices for individual i’s contacts. We assume that
Y ti ⊥ Y
r
j |


∑
m∈Ai:Vm=v
Y t−bm , v = 0, 1

 , for all j /∈ Ai and r ≤ t. (11)
The set in the conditioning event includes the number of vaccinated contacts of individual i
who were sick on or before day t−b and the number of unvaccinated contacts of individual i who
were sick on or before day t−b. This assumption says that the outcome of individual i at time
t is independent of all past outcomes for non-contacts of i, conditional on a summary measure
of the flu history of the contacts of i. In other words, contacts act as a causal barrier between
two nodes who do not themselves share a tie. If two individuals, i and j, do not share a tie,
then they can have no effect on one another’s disease status that is not through their contacts’
disease statuses. Because t− b is the latest time at which a disease transmission could affect
Y ti , we do not need to condition on the contacts’ outcomes past that time. This assumption
implies that the total number of vaccinated and unvaccinated contacts of individual i who
have been sick by day t− b are a sufficient summary measure of the complete history of all of
i’s contacts. It could easily be modified so that the probability of being infected at any given
time depends on a different summary measure, for example on the proportion of alters who
were infectious at or before time t− b.
We also assume that
Y ti ⊥ Vj |


∑
m∈Ai:Vm=v
Y t−bm , v = 0, 1

 for all j /∈ Ai (12)
and that, for any covariate C that is required for (1) through (4) to hold,
Y ti ⊥ Cj |


∑
m∈Ai:Vm=v
Y t−bm , v = 0, 1

 for all j /∈ Ai. (13)
These assumptions state that any effect of the covariates (including vaccination) of nodes
without ties to i on i’s disease status would again have to be mediated by the disease statuses
of i’s contacts. Assumption (12) implies that the infectiousness effect is not transitive: whether
individual j caught the flu from a vaccinated or unvaccinated person has no influence on
whether individual j transmits the flu.
Embedded in assumptions (11)-(13) is the assumption that all ties are equivalent and all
non-ties are equivalent with respect to transmission of the outcome. This is likely to be a
simplification of reality. It can be relaxed (see Section 5.3), but we make it now for heuristic
purposes. It rules out the possibility that some types of ties, like roommates, are more likely
to facilitate disease transmission than others, like friends who live in different dorms. It allows
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an individual to come into contact with and possibly infect (or be infected by) people with
whom he does not share a tie, but it entails that he will come into contact with any individual
in the network who is not his contact with equal probability. This rules out, for example, the
possibility that an individual is more likely to be infected by the friends of his friends than by
a distant node on the network.
We also make the no-unmeasured-confounding assumption that, if there exists a person
with whom two individuals in the network interact regularly, then that person is also in the
network (with ties to both individuals). In some settings it may be possible to satisfy this
condition, e.g. in full sociometric studies conducted de novo, or in studies of online data.
5.2 Estimation and hypothesis testing
Consider the following strategy for estimating a new contagion and new infectiousness effect,
defined below:
1. Randomly select from the network K pairs of nodes such that the two nodes in each
pair share a tie, but, for each pair, neither node nor any of their contacts has a tie to a
node in any other pair or to the contacts of any member of any other pair. The number
of possible such pairs will depend on the network size and topology. In the next section,
we discuss methods for sampling these pairs. Randomly select one member of each pair
to be the ego and one to be the alter.
2. Index the pairs by k, and let ek index the ego and ak the alter in the k
th pair. For
the kth pair, define a group, also indexed by k, that includes nodes ak, ek, Aek , and
Aak . That is, it includes the alter-ego pair and all nodes with ties to either the alter or
the ego. Due to the way we selected pairs, none of the members of group k can belong
to any other group. Below, we suppress the index k when context allows. As in the
sections above, Tk is the time of the first infection in the pair (ak, ek). Let Ck be a
collection of covariates for group k, where the variables included in C are precisely those
required for assumptions (1) through (4) to hold for outcome Y
T (1)+b
e , mediator Y
T (1)
a ,
and treatment Va. Note that Ve should be included in C as it is likely to be a confounder
of the mediator - outcome relationship. The number of mutual contacts of the alter and
ego who were sick by time T − b must also be included.
3. Let UTk+fek and L
Tk+f
ek
be the number of unvaccinated and vaccinated nodes, respectively,
with ties to ek who were sick by time Tk + f . Define U
T−b
ak
and LT−bak similarly as the
number of unvaccinated and vaccinated nodes, respectively, with ties to ak who were sick
by time Tk − b. Recall that f is the infectiousness period and b the incubation period,
defined in Section 3.2.1.
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4. Estimate an average modified contagion effect
Con∗ =
E
[
Y
T (1)+s
e (0, Y
T (1)
a (1)) | UT−ba , L
T−b
a , U
T+f
e , L
T+f
e ,C
]
E
[
Y
T (0)+b
e (0, Y
T (0)
a (0)) | U
T−b
a , L
T−b
a , U
T+f
e , L
T+f
e ,C
]
and an average modified infectiousness effect
Inf∗ =
E
[
Y
T (1)+s
e (1, Y
T (1)
a (1)) | UT−ba , L
T−b
a , U
T+f
e , L
T+f
e ,C
]
E
[
Y
T (1)+s
e (0, Y
T (1)
a (1)) | U
T−b
a , L
T−b
a , U
T+f
e , L
T+f
e ,C
]
and their standard errors.
Through Step 2, the procedure we described is nearly identical to the proposal in Section 4,
the only difference being that groups are extracted from a network in Step 1 rather than being
independently ascertained. Consideration for this sampling scheme becomes crucial when we
estimate the parameters of GLMs like (5) and (6). The standard errors derived from these
GLMs are consistent only if the residuals across groups are uncorrelated. The residuals are
indeed uncorrelated for independent groups, but, in the network setting, they generally are
not. However, the set of additional covariates introduced in Step 3 essentially blocks the flow
of information between groups. Conditional on these additional covariates, the residuals are
uncorrelated, even in the network setting (see next section for proof). Roughly, because UTk+fek
and LTk+fek summarize the disease statuses of the ego’s contacts b days before the outcome
Y
T (1)+s
ek is assessed, conditioning on them ensures that the outcomes are uncorrelated across
groups. Because UT−bak and L
T−b
ak
summarize the disease statuses of the alter’s contacts b
days before the mediator Y
T (1)
ak is assessed, conditioning on them ensures that mediators are
uncorrelated across groups.
The effects defined in Step 4 differ from Con and Inf only in the conditioning set, but
this changes slightly the causal effect being estimated. Conditioning on UT−ba and L
T−b
a is just
like conditioning on an extra pair of confounders: these variables occur before the mediator
and are independent of the treatment; therefore they can be considered to be pre-treatment
covariates. On the other hand, UT+fe and L
T+f
e occur after the mediator and lie on a possible
pathway from the mediator to the outcome. Conditioning on these variables has the effect of
biasing Con∗ and Inf∗ towards the null relative to Con and Inf , because it blocks the path
from Y Ta to Y
T+s
e that operates when the alter infects a friend of the ego, who then infects
the ego. However, conditioning on these variables leaves the direct path from Y Ta to Y
T+s
e
open, and this path operates whenever the alter infects the ego directly. Therefore, whenever
Con and Inf are non-null so are Inf∗ and Con∗. Hypothesis tests using Con∗ and Inf∗ are
conservative and consistent for hypothesis tests for Con and Inf . Similarly, tests that Con∗
and Inf∗ are less than the null value or are greater than the null value are also valid and
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consistent for the analogous tests for Con and Inf , respectively.
5.2.1 Justification for the use of GLMs
Suppose that the models
g(E
[
Y Tk+sek | Vak , Y
Tk
ak
= 1, UT−ba , L
T−b
a , U
T+f
e , L
T+f
e ,Ck
]
) (14)
= β0 + β1Vak + β2U
T−b
a + β3L
T−b
a + β4U
Tk+f
e + β5L
Tk+f
e + β
′
6Ck
and
m(E
[
Y Tkak | Vak , U
T−b
a , L
T−b
a , U
T+f
e , L
T+f
e ,Ck
]
)
= α0 + α1Vak + α2U
Tk−b
a + α3L
Tk−b
a + α4U
Tk+f
e + α5L
Tk+f
e + α
′
6Ck (15)
are correctly specified for g(), m() known link functions. For the effect on the ratio scale with
a binary common outcome like the flu we would specify g() to be the log link and m() the logit
link, like we did in Sections 3 and 4. We have only to prove that the residuals from model (14)
are uncorrelated with one another and that the residuals from model (15) are uncorrelated
with one another (Breslow, 1996; Gill, 2001).
Result 1 Let Resak = Y
Tk
ak
−m−1
(
α0 + α1Vak + α2U
Tk−b
a + α3L
Tk−b
a + α4U
Tk+f
e + α5L
Tk+f
e + α
′
6Ck
)
.
Then Resak and Resah are uncorrelated.
Proof Without loss of generality assume that Tk > Th. Under correct specification of (15),
E[Resak ] = E[Resah ] = 0. Therefore Cov(Resak , Resah) = E [ResakResah ]. Letting Sk
denote the set of variables
{
Vak , U
T−b
a , L
T−b
a , U
T+f
e , L
T+f
e ,Ck
}
, we have
E [ResakResah ]
= E [E [ResakResah | Sk, Sh]]
= E
[
E
[{
Y Tkak −E
[
Y Tkak | Sk
]}{
Y Thah − E
[
Y Thah | Sh
]}
| Sk, Sh
]]
= E
[
E
[
Y Tkak − E
[
Y Tkak | Sk
]
| Sk, Sh
]
× E
[
Y Thah − E
[
Y Thah | Sh
]
| Sk, Sh
]]
= E
[{
E
[
Y Tkak | Sk, Sh
]
− E
[
Y Tkak | Sk
]}
× E
{
Y Thah − E
[
Y Thah | Sh
]
| Sk, Sh
}]
= E
[{
E
[
Y Tkak | Sk
]
− E
[
Y Tkak | Sk
]}
× E
{
Y Thah − E
[
Y Thah | Sh
]
| Sk, Sh
}]
= 0.
The second equality follows from the correct specification of (15). The third equality
holds because, by assumptions (11), (12), and (13), Y Tkak ⊥ Y
Th
ah
| Sk, Sh. The fifth
inequality holds because Y Tkak ⊥ Sh | Sk, again by assumptions (11), (12), and (13).
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Result 2 Let Resek = Y
Tk+s
ek
−g−1
(
β0 + β1Vak + β2U
Tk−b
ak
+ β3L
Tk−b
ak
+ β4U
Tk+f
e + β5L
Tk+f
ek
+ β′6Ck
)
.
Then Resak and Resah are uncorrelated.
The proof of Result 2 is very similar to the proof of Result 1 and we therefore omit it. It relies
on the fact that, conditional on the fact that T + f = T + s − b and therefore conditioning
on UTk+fek and L
Tk+f
ek
satisfies the conditions of assumptions (11), (12), and (13) and renders
Y Tk+sek independent of outcomes, vaccines, and covariates for other groups.
5.2.2 Implementation
Step 1 is the most difficult to implement. One could enumerate all possible ways of parti-
tioning the network into non-overlapping groups comprised of a pair of nodes and all of their
contacts, associate the partitions with a discrete uniform distribution, and randomly sample
one realization of the uniform distribution. Steps 2 and 3 of the testing procedure are per-
functory. If we define C∗ =
(
UT−ba , L
T−b
a , U
T+f
e , L
T+f
e ,C
)
to be a new collection of covariates
then step 4 proceeds as in Sections 3 and 4. Interactions between components of C∗ and the
other predictors in the model can easily be accommodated. To test the hypotheses that Con
and Inf are null, we estimate 95% confidence intervals for the modified contagion and infec-
tiousness estimands (Con∗ and Inf∗) based on the estimates and standard errors calculated
in Step 4. We reject the hypothesis that Con is null if our confidence interval for the estimand
in Con∗ does not include the null value and we reject the hypothesis that Inf is null if our
confidence interval for the estimand in Inf∗ does not include the null value.
5.3 Relaxing some assumptions
We assumed throughout that vaccination occurs before the start of follow-up, but this is
not necessary for our methods. If vaccination can occur during follow-up, define V ti to be an
indicator of having been vaccinated by time t. Assume that the effect of vaccination, including
any infectiousness effect, is immediate. If an individual becomes infectious on day T , he would
have been infected on day T−b. If he was vaccinated by time T−b, then the vaccine would have
been in full effect at the time of infection. Then V T−ba can replace Va as the “treatment” in the
contagion, infectiousness, and indirect effects. We similarly redefine the summary measures
for vaccinated and unvaccinated contacts of the alter and ego that appear in assumptions (11)
through (13) and that are included in C. Include V T−be in the set of confounders because the
mediator occurs at time T and therefore the ego’s vaccination status at time T − b suffices to
control for any confounding.
We assumed throughout that the infectious and incubation periods (f and b) are constant
across individuals. These assumptions, along with the assumption that the effect of vaccination
is immediate, could be relaxed if the determinants of time to efficacy of vaccine, length of
infectious period, and length of incubation period were observed covariates. In this case we
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could, for example, infer effective time of vaccination, incubation period, and infectious period
for each individual based on their covariates.
We assumed in Section 5.2 that the probability of disease transmission between two con-
nected nodes does not depend on the type of tie. This assumption can be avoided with the
addition of several covariates to models (14) and (15): we would condition on the type of tie
that exists between the alter and the ego, and also include separate U and L terms for each
type of tie. We also assumed in Section 5.2 that an individual will come into contact with any
individual in the network who is not his contact with equal probability. This can be relaxed
by expanding the k groups we define in Step 1 of the estimation procedure to include nodes
within several degrees of separation from the alter and ego.
6 Simulations
6.1 Independent groups
We ran simulations for three different sample sizes, K = 200, K = 500, and K = 1000
independent groups. Each group comprised an alter, an ego, and nk mutual contacts. First
we generated K contact group sizes nk by sampling from a Poisson distribution with mean
λ = 3. Next, we assigned vaccination statuses to each individual in each group, including the
alters and egos, with probability 0.4. We simulated the behavior of each group during a flu
epidemic over 100 days. For the purposes of the simulation, we assumed that each member
of a group had contact with all other members of the same group. Each day, an uninfected
member of a group had a baseline probability of po of being infected from outside of the group,
a baseline probability of pu of being infected by any infectious, unvaccinated member of the
same group and a baseline probability of pv of being infected by any infectious, vaccinated
member of the same group. If vaccinated, an individual’s probability of being infected by any
source was multiplied by δ ≤ 1. If infected on day t, an individual was infectious from day
t + 1 through day t + 4 and incapable of being infected or transmitting infection from day
t + 5 until the end of follow-up. This corresponds to an incubation period of b = 1 and an
infectious period of f = 3, and it mimics the flu, for which the incubation period is between
one and three days and the infectious period is between three and six days (Earn et al., 2002).
In all simulations, we fixed po = 0.01. We specified two different simulation settings for
the parameters δ, pv, and pu, one setting corresponding to the null of no infectiousness or
contagion effects (δ = 1; pv =pu = 0.4) and one setting corresponding to the presence of
protective contagion and infectiousness effects (δ = 0.1; pv = 0.5, pu = 0.05). We simulated
500 epidemics each under of the two scenarios, and for each simulation we estimated the
infectiousness and contagion effects as follows: Among the subset of groups with Y Ta = 1
and using a log-linear link function, we regressed Y T+se on Va and on the set of potential
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Table 1: Simulation results for independent groups
Under H0
Number of groups Infectiousness (SE) Coverage Contagion (SE) Coverage
K = 200 1.014 (0.138) 94% 1.016 (0.202) 94%
K = 500 1.001 (0.082) 92.2% 0.997 (0.117) 93.6%
K = 1000 0.997 (0.057) 95% 1.001 (0.083) 94%
Under HA
Number of groups Infectiousness (SE) Power Contagion (SE) Power
K = 200 0.453 (1.160) 49% 0.258 (0.079) 100%
K = 500 0.443 (0.154) 86% 0.255 (0.049) 100%
K = 1000 0.445 (0.107) 100% 0.258 (0.034) 100%
confounders comprised by the ego’s vaccination status, the sum UT−ba of unvaccinated mutual
contacts who were infectious at time T − b, and the sum LT−ba of vaccinated mutual contacts
who were infectious at time T − b. We regressed Y Ta on the same covariates using a logistic
link function. The contagion and infectiousness effects are identified by the expressions given
in (7) and (8), evaluated at the sample mean value of the covariates UT−ba and L
T−b
a . We
bootstrapped the standard errors with 500 bootstrap replications.
The results are given in Table 1. For each simulation setting, that is, for each sample size
(K) and for both the null hypothesis and the alternative hypothesis, we present the mean point
estimates for the infectiousness and contagion effects on the ratio scale, the mean bootstrap
standard error estimator, and the percent coverage of the 95% confidence interval based on
the 2.5th and 97.5th bootstrap quantiles. For simulations under the null hypothesis, we report
coverage and for simulations under the alternative we report power, given by 100% minus the
percent coverage. The point estimates are stable across sample sizes and the coverage of the
basic bootstrap confidence interval is close to 95% under the null for all K. The power under
the alternative is 100% for the contagion effect, but for the infectiousness effect power is low
(49%) when K = 200.
6.2 Social network data
The procedure proposed in Section 5.2 for hypothesis testing using social network data suffers
from low power. In part this is because Con∗ and Inf∗ are biased towards the null relative to
Con and Inf , but the primary reason for the loss of power is the extraction of conditionally
independent pairs of nodes from the network. As the simulation illustrates, this results in a
dramatic reduction in the sample size used for analysis. Because infectious outcomes sam-
pled from nodes in a network are dependent, the effective sample size for inference about such
outcomes will always be smaller than the observed number of nodes, and how much more infor-
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mation about the parameters of interest is available depends on the specific setting. Important
areas for future research include determining the effective sample size when observations are
sampled from a network and are therefore dependent, and developing methods that make use
of all available information.
We ran simulations for three different network sizes: 12000 nodes, 10000 nodes, and 8000
nodes. We simulated a network of 10000 nodes as follows: first, we simulated 2000 independent
groups of 5 nodes, with each group being fully connected (i.e. there are ties between each pair
of nodes in the group of 5). For each node we then added a tie to each out-of-group node with
probability 0.0001. Because ties are undirected (if node i is tied to node j, then by definition
node j is tied node i), this results in approximately 2 expected out-of-group ties per node. To
simulate networks of size 12000 and 8000, we simulated 2400 and 1600 independent groups,
respectively, and scaled the probability of an out-of-group tie to maintain an expected value
of approximately 2 for each node. This network structure could represent a sample of families
living in a city, where individuals are fully connected to the members of their family and
occasionally connected to members of other families. After running step 1 of the procedure
outlined in Section 5.2, we were left with K = 707 alter-ego pairs for the network of size 12000,
K = 581 for the network of size 10000, and K = 466 for the network of size 8000.
On each of these three fixed networks, we simulated 200 epidemics under the null of no
infectiousness or contagion effect and 200 epidemics under the alternative. For each simulation,
we assigned vaccination statuses to each individual in the network with probability 0.5. We
then simulated the behavior of each group during a flu epidemic over 100 days. An uninfected
node had a probability of po = 0.01 of being infected from outside of the network on day 1 and
there were no outside infections thereafter. Under the alternative, on each day an uninfected
node had a baseline probability of pu = 0.5 of being infected by any infectious, unvaccinated
contact and group and a baseline probability of pv = 0.01 of being infected by any infectious,
vaccinated contact. If vaccinated, an individual’s probability of being infected by any source
was multiplied by δ = 0.2. Under the null, on each day an uninfected node had a probability
of pu = pv = 0.5 of being infected by any infectious contact (that is, node with which it shared
a tie). To ensure that the contagion effect was null, we specified that δ = 1, that is, that
vaccination had no protective effect against contracting the flu. In both settings, if infected
on day t an individual was infectious from day t+1 through day t+4 and incapable of being
infected or transmitting infection from day t+ 5 until the end of follow-up.
For each simulation, we estimated the infectiousness and contagion effects following the
procedure described in Section 5.2. We evaluated these effects at the sample mean value of
the covariates UT−ba , L
T−b
a , U
T+f
e and L
T+f
e . We bootstrapped the standard errors with 1000
bootstrap replications. The results are given in Table 2. For each simulation setting, that
is for each network size and for both the null hypothesis and the alternative hypothesis, we
present the mean point estimates for the infectiousness and contagion effects on the ratio
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Table 2: Simulation results for network data
Under H0
Network size Infectiousness (SE) Coverage Contagion (SE) Coverage
8000 nodes 0.996 (0.001) 100% 1.205 (1.657) 96%
10000 nodes 1.000 (0.001) 100% 1.183 (1.183) 94%
12000 nodes 1.001 (0.001) 100% 1.166 (0.) 94%
Under HA
Network size Infectiousness (SE) Power Contagion (SE) Power
8000 nodes 0.650 (0.259) 45% 0.168 (0.017) 99%
10000 nodes 0.616 (0.072) 53% 0.164 (0.013) 100%
12000 nodes 0.609 (0.054) 63% 0.164 (0.010) 100%
scale, the mean bootstrap standard error estimator, and the percent coverage of the 95%
confidence interval based on the 2.5th and 97.5th bootstrap quantiles. For simulations under
the alternative hypothesis we calculated the power, given by 100% minus the percent coverage.
For the 8000- and 10000-node networks, there were 6 and 1 simulations, respectively, out of
200, for which the GLMs used to estimate the parameters involved in the contagion and
infectiousness effects did not converge due to empty strata of the predictors. We omit these
simulations from the results in Table 2, but note that in a extreme cases convergence could be
an issue in addition to power.
The point estimates are stable across network sizes and the coverage of the basic bootstrap
confidence interval is close to or above 95% under the null for all network sizes. The power
under the alternative is close to 100% for the contagion effect for all network sizes, but for the
infectiousness effect power is low: 45% for the network of size 8000, increasing to 63% for the
network of size 12000.
One concern that has been raised about previous uses of statistical models like GLMs and
GEEs for network data is the possibility that the models lack any power to reject the null
hypothesis when the alternative is true (Shalizi, 2012). This is a concern because the models
are inherently misspecified under the alternative hypothesis, even if they are correctly specified
under the null hypothesis. Because the methods we propose here can be correctly specified
under both the null and the alternative hypotheses, they can be powered to reject the null
hypothesis when the infectiousness or contagion effect is present.
7 Discussion
We proposed methods for consistently estimating contagion and infectiousness effects in in-
dependent groups of arbitrary size; these methods are easy to implement and perform well
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in simulations. We extended our methodology to groups sampled from social network data,
providing a theoretically justified method for using GLMs to analyze network data. Note
that the principles we applied to GLMs can be applied to GEEs as well, resulting in correctly
specified GEEs for network data. The principles that justify our use of GLMs to estimate the
contagion and infectiousness effects are easily extended to any estimand for which GLMs would
be a desirable modeling tool. However, our network data methods require a large amount of
data and are not appropriate for small or dense networks. On the one hand this highlights
the fact that dependence among observations in networks reduces effective sample size and
necessitates larger samples; on the other hand methods should be developed that can harness
more information from the data and increase the power to detect contagion, infectiousness,
and other causal effects.
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